We surface real-world practices and perspectives across gynecologic cancers

Four chair-led formats, each built for a different clinical conversation. Every program is unbranded, independently run, and reported without attribution. Industry partners gain access to a series of regional de-identified insight reports capturing how specialists across a region are approaching gynecologic cancer care.

Programs

Different questions call for different formats

Different questions call for different formats

Landscape ROUNDS

Real-world Observations on Unmet Needs, Decisions & Strategies

A regional roundtable series on how clinicians are managing patients now, how they read emerging data, and where they expect the landscape to move.

Who’s in the room

A focused group of oncologists managing gynecologic cancers, spanning university and community practice, moderated by one or more expert chairs.

How it runs

In person or virtually, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

Landscape ROUNDS

Real-world Observations on Unmet Needs, Decisions & Strategies

A regional roundtable series on how clinicians are managing patients now, how they read emerging data, and where they expect the landscape to move.

Who’s in the room

A focused group of oncologists managing gynecologic cancers, spanning university and community practice, moderated by one or more expert chairs.

How it runs

In person or virtually, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

PAIR Roundtables

Physician and APP Interactive Roundtables

A roundtable series built around hypothetical case scenarios, where the chairs walk through a hypothetical case and open discussion at each key decision point on how the room would manage the patient.

Who’s in the room

A focused group from the broader gynecologic cancer care team, co-led by a gynecologic oncology expert and an advanced practice provider.

How it runs

In person or virtually, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

PAIR Roundtables

Physician and APP Interactive Roundtables

A roundtable series built around hypothetical case scenarios, where the chairs walk through a hypothetical case and open discussion at each key decision point on how the room would manage the patient.

Who’s in the room

A focused group from the broader gynecologic cancer care team, co-led by a gynecologic oncology expert and an advanced practice provider.

How it runs

In person or virtually, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

Congress LENS

Latest Evidence, New Strategies

A congress-adjacent series that captures how clinicians read breaking data, followed by regional virtual roundtables on how that data is perceived across settings.

Who’s in the room

A focused group of clinicians per session, co-chaired by two gyn onc experts. The congress session skews academic; the regional sessions that follow reach community practice.

How it runs

One in-person discussion during the congress, followed by virtual programs across select regions.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

Congress LENS

Latest Evidence, New Strategies

A congress-adjacent series that captures how clinicians read breaking data, followed by regional virtual roundtables on how that data is perceived across settings.

Who’s in the room

A focused group of clinicians per session, co-chaired by two gyn onc experts. The congress session skews academic; the regional sessions that follow reach community practice.

How it runs

One in-person discussion during the congress, followed by virtual programs across select regions.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

Trial SCOPE

Scientific Collaboration on Oncology Protocols & Eligibility

A virtual roundtable series on familiarity with regionally available gynecologic cancer trials and their eligibility criteria, and what gets in the way of enrollment and retention.

Who’s in the room

A focused group of clinicians who treat gynecologic cancers across academic and community settings, led by an established gyn onc clinical researcher.

How it runs

Virtual, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

Trial SCOPE

Scientific Collaboration on Oncology Protocols & Eligibility

A virtual roundtable series on familiarity with regionally available gynecologic cancer trials and their eligibility criteria, and what gets in the way of enrollment and retention.

Who’s in the room

A focused group of clinicians who treat gynecologic cancers across academic and community settings, led by an established gyn onc clinical researcher.

How it runs

Virtual, as a series across select regions, with the first program typically underway within weeks of kickoff.

What you get

Silent observer seats during each program, with a Rapid Readout, Recap, and Roll-up delivered on a fast turnaround as the series runs.

By the numbers

Two years of gynecologic oncology, by the numbers.

The scope of our work and the network behind it, in one place.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.